Cite
Fourgeaud C, Derieux S, Mirshahi S, et al. PO-23 - Expression of heparanase in cancer as biomarker of malignancies: overexpression in an aggressive, poor survival gastric cancer "gastric signet ring cell carcinoma" compared with that of other gastric cancers. Thromb Res. 2016;140:S184-5doi: 10.1016/S0049-3848(16)30156-6.
Fourgeaud, C., Derieux, S., Mirshahi, S., Besbes, S., Chidiac, J., Mahé, I., Contant, G., Pocard, M., Soria, J., & Mirshahi, M. (2016). PO-23 - Expression of heparanase in cancer as biomarker of malignancies: overexpression in an aggressive, poor survival gastric cancer "gastric signet ring cell carcinoma" compared with that of other gastric cancers. Thrombosis research, 140S184-5. https://doi.org/10.1016/S0049-3848(16)30156-6
Fourgeaud, C, et al. "PO-23 - Expression of heparanase in cancer as biomarker of malignancies: overexpression in an aggressive, poor survival gastric cancer "gastric signet ring cell carcinoma" compared with that of other gastric cancers." Thrombosis research vol. 140 (2016): S184-5. doi: https://doi.org/10.1016/S0049-3848(16)30156-6
Fourgeaud C, Derieux S, Mirshahi S, Besbes S, Chidiac J, Mahé I, Contant G, Pocard M, Soria J, Mirshahi M. PO-23 - Expression of heparanase in cancer as biomarker of malignancies: overexpression in an aggressive, poor survival gastric cancer "gastric signet ring cell carcinoma" compared with that of other gastric cancers. Thromb Res. 2016 Apr;140:S184-5. doi: 10.1016/S0049-3848(16)30156-6. Epub 2016 Apr 08. PMID: 27161709.
Copy
Download .nbib